Skip to Content
Merck
CN

Regulation of NANOG in cancer cells.

Molecular carcinogenesis (2015-05-28)
Shuai Gong, Qiuhui Li, Collene R Jeter, Qingxia Fan, Dean G Tang, Bigang Liu
ABSTRACT

As one of the key pluripotency transcription factors, NANOG plays a critical role in maintaining the self-renewal and pluripotency in normal embryonic stem cells. Recent data indicate that NANOG is expressed in a variety of cancers and its expression correlates with poor survival in cancer patients. Of interest, many studies suggest that NANOG enhances the defined characteristics of cancer stem cells and may thus function as an oncogene to promote carcinogenesis. Therefore, NANOG expression determines the cell fate not only in pluripotent cells but also in cancer cells. Although the regulation of NANOG in normal embryonic stem cells is reasonably well understood, the regulation of NANOG in cancer cells has only emerged recently. The current review provides a most updated summary on how NANOG expression is regulated during tumor development and progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
NANOG human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture